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Klebsiella pneumoniae is an important cause of community-onset pneumonia in Asian
countries and South Africa. We investigated the clinical characteristics of K. pneumo-
niae causing community-onset pneumonia, and the associated microbiological features
between K. pneumoniae isolates from pneumonia and those from the nasopharynx
in Taiwan. This study was conducted at the Taipei Veterans General Hospital during July,
2012 to February, 2014. The clinical characteristics in patients with community-onset K.
pneumoniae pneumonia were analyzed. K. pneumoniae isolates from the nasopharynx
of adults attending otorhinolaryngology outpatient clinics were collected to compare their
microbiological features with those from pneumonia. Capsular genotypes, antimicrobial
susceptibility, andmultilocus sequence type (MLST)were determined among these strains.
Ninety-one patients with community-onset K. pneumoniae pneumonia were enrolled.We
found a high mortality (29.7%) among these patients. Capsular types K1, K2, K5, K20, K54,
andK57 accounted for∼70%of theK. pneumoniae isolates causing pneumonia, and∼70%
of all the K. pneumoniae strains isolated from the nasopharynx of patients in outpatient
clinics. The MLST proﬁles further demonstrated the genetic relatedness between most
pneumonia isolates and those from the nasopharynx. In conclusion, our results show that
community-onset pneumonia caused by K. pneumoniae was associatedwith highmortality
and could have a reservoir in the nasopharynx. To tackle this high-mortality disease, the
distribution of capsular types in the nasopharynx might have implications for future vaccine
development.
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INTRODUCTION
Klebsiella pneumoniae is recognized 100 years ago as a potential
cause of community-acquired pneumonia (CAP). However, over
the past few decades, K. pneumoniae has been a rare cause of CAP
in North America, Europe, and Australia (Shon et al., 2013). By
contrast, it is an important cause of lower respiratory tract infec-
tion (LRTI) in Asian countries and South Africa and is associated
with high mortality (Wang et al., 2005; Yu et al., 2007; Song et al.,
2008; Lin et al., 2010a,b). In one prospective surveillance study
from eight Asian countries, Streptococcus pneumoniae (29.2%)
was the most common bacterial pathogen, followed by K. pneu-
moniae (15.4%; Song et al., 2008). In Cambodia, K. pneumoniae
accounted for 8% of community-acquired LRTI (Rammaert et al.,
2012). A previous study in an island in the Indian Ocean 2,500 km
east of the South African coast demonstrated that S. pneumoniae
and K. pneumoniae (42 and 22%, respectively) were the most fre-
quent microbial agents in CAP patients admitted to intensive care
units (Paganin et al., 2004).
In Western countries, although K. pneumoniae is a rare cause
of CAP, one recent study highlighted that CAP caused by K. pneu-
moniae was associated with increased risk of cardiovascular events
following this infection (Grifﬁn et al., 2013). Recently, the emer-
gence of fatal bacteremic CAP due to K. pneumoniae was reported
in France (Decre et al., 2011; Rafat et al., 2013). This suggests that
the re-emergence of severe K. pneumoniae pulmonary infections
in Western countries cannot be overlooked.
Klebsiella pneumoniae, especially the virulent capsular types
K1 and K2, has emerged as the major cause of community-
acquired liver abscess in the past three decades in East Asia,
especially Taiwan (Fung et al., 2002; Fang et al., 2004; Lin et al.,
2013). However, the clinical features and microbiological charac-
teristics of K. pneumoniae causing community-onset pneumonia
have rarely been addressed (Lin et al., 2010a,b). The patho-
genesis of K. pneumoniae causing community-onset pneumo-
nia is unknown and nasopharyngeal colonization may precede
pneumonia.
In the current study, we investigated the clinical features of
community-onset pneumonia caused by K. pneumoniae in our
hospital. We further compared the microbiological characteris-
tics between K. pneumoniae strains from the nasopharynx in
adult patients attending otorhinolaryngology outpatient clinics
and those from community-onset pneumonia.
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MATERIALS AND METHODS
STUDY DESIGN AND PATIENTS
A retrospective study was carried out in the Taipei Veterans Gen-
eral Hospital from July, 2012 to February, 2014. All consecutive
adult patients (aged> 20 years) admitted with community-onset
pneumonia due to K. pneumoniae were included. Community-
onset pneumonia refers to both CAP and healthcare-associated
pneumonia (HCAP). Polymicrobial infections were excluded in
this study. CAP, HCAP, and hospital-acquired pneumonia were
diagnosed based on the criteria previously described (Maruyama
et al., 2013). HCAP included patients with pneumonia and any of
the following: (1) hospitalization for 2 days during the preceding
90 days; (2) residence in a nursing home or extended care facil-
ity; (3) home infusion therapy (including antibiotics); (4) chronic
dialysis (including haemodialysis and peritoneal dialysis) during
the preceding 30 days; or (5) home wound care. Taiwan is endemic
forK. pneumoniae liver abscess and cases of liver abscesswith septic
lung metastasis were also excluded.
We also consecutively collected K. pneumoniae isolates from
the nasopharyngeal region in adult patients (aged > 20 years)
attending otorhinolaryngology outpatient clinics from July, 2013
to February, 2014 to determine their clinical and microbiological
characteristics. Themaindiagnosis of patients attendingotorhino-
laryngology outpatient clinics during this study period were acute
sinusitis, chronic sinusitis, and allergic rhinitis. The protocol was
approved by the hospital’s institutional review board.
DATA COLLECTION AND OUTCOME MEASURES
The following data were collected on admission to hospital: age,
sex, comorbid illnesses, clinical symptoms, concomitant bac-
teremia, and antimicrobial treatment. The Pneumonia Severity
Index (PSI) was determined in all patients (Fine et al., 1997). In
this observational study, we focused on the following endpoints:
28-day and in-hospital mortality, receiving mechanical ventilation
during hospitalization and requiring intensive care.
MICROBIOLOGICAL EVALUATION
The Vitek 2 automated system (bioMérieux, Marcy l’Etoile,
France) was used for bacterial identiﬁcation and antimicrobial
susceptibility testing. The following antimicrobial agents were
assayed: ampicillin, cefazolin, cefuroxime, cefoxitin, ceftriax-
one, ceftazidime, cefepime, piperacillin–tazobactam, ertapenem,
imipenem, amikacin, gentamicin, ciproﬂoxacin, levoﬂoxacin,
trimethoprim–sulfamethoxazole, and tigecycline. To determine
the capsular genotypes of K. pneumoniae, we undertook cps
genotyping by the polymerase chain reaction detection of K-
serotype-speciﬁc alleles at wzy loci, including serotypes K1, K2,
K5, K20, K54, and K57, as described previously (Fang et al.,
2007). Other capsular types were determined by a simple and
useful capsular genotyping method for K. pneumoniae based on
wzc sequences as described previously (Pan et al., 2013). rmpA
(regulator of the mucoid phenotype), a gene known as an extra-
capsular polysaccharide synthesis regulator, can positively control
the mucoid phenotype of K. pneumoniae. The presence of rmpA
was proposed as an important virulence factor (Yu et al., 2006).
One recent study showed that plasmid rmpA genes could be co-
inherited together with the adjacent virulence genes carried by a
large plasmid in K. pneumoniae (Hsu et al., 2011). Plasmid rmpA
and rmpA2 genes were determined as described previously (Hsu
et al., 2011).
Multi-locus sequence type (MLST) was performed on all iso-
lates according to the protocol described on the K. pneumoniae
MLST website (http://www.pasteur.fr/recherche/genopole/PF8/
mlst/). MLST results were analyzed using the international
K. pneumoniae MLST database created in 2005 at the Pasteur
Institute in Paris, France (Diancourt et al., 2005).
STATISTICAL ANALYSIS
The χ2 test or Fisher’s exact test were used in the comparison of
categorical data, and the Student’s t-test or Mann–Whitney U test
were used for the comparison of continuous variables. Univariate
and multivariate logistic regression analyses were performed to
predict 28-day mortality. Variables that showed a signiﬁcant dif-
ference (P < 0.1) in the univariate analysis were included in the
forward likelihood ratio, stepwise multivariate logistic regression
model to determine if any of them were independently related to
outcome. Analysis was performed using SPSS version 19.0 (SPSS
Inc., Chicago, IL, USA) with P < 0.05 considered statistically
signiﬁcant.
RESULTS
CLINICAL CHARACTERISTICS OF PATIENTS WITH COMMUNITY-ONSET
K. pneumoniae PNEUMONIA AND RISK FACTORS FOR MORTALITY
During the study period, a total of 191 consecutive patients with
monomicrobial K. pneumoniae pneumonia were identiﬁed. Of
these patients, 91 (47.6%) were classiﬁed as having community-
onset infection, and the remaining 100 (52.6%) were classiﬁed as
having hospital-acquired infection. Among the 91 patients diag-
nosed with community-onset K. pneumoniae pneumonia, there
was a male predominance (n = 76) and the mean age was
77.9 ± 11.7 years. CAP accounted for 51.6% (n = 47) of the
patients. None of the cases had concomitant distant abscesses. The
28-day mortality was 29.7% (27 patients). The overall in-hospital
mortality was 34.1% (31 patients). Table 1 lists the clinical fea-
tures of CAP and HCAP. HCAP patients had a signiﬁcantly higher
Charlson Comorbidity Index and PSI scores than CAP patients.
CAP patients had a higher level of appropriate antibiotic use. Both
the 28-day mortality and in-hospital mortality were not different
statistically between CAP and HCAP.
MICROBIOLOGICAL CHARACTERISTICS OF K. pneumoniae FROM
PATIENTS WITH COMMUNITY-ONSET PNEUMONIA
Table 2 shows the distribution of capsular type among K. pneu-
moniae isolates. Capsular types K1, K2, K5, K20, K54, and K57
accounted for 67% (61/91) of all the K. pneumoniae isolates. Dur-
ing the same collection period for K. pneumoniae isolates from
outpatients, the rate of capsular types K1, K2, K5, K20, K54, and
K57 was consistent (72%, 31/43). Plasmid rmpA and rmpA2 genes
were identiﬁed in 65 and 63 isolates, respectively. All but two
strains belonging to the six capsular types (K1, K2, K5, K20, K54,
and K57) carried the plasmid rmpA or rmpA2 genes. Seventy-one
of the 91 (78%) isolates had the wild-type antibiotic susceptibility
(susceptible to several classes of antibiotics, except for intrinsic
resistance to ampicillin). MLST proﬁles were further determined
Frontiers in Microbiology | Infectious Diseases February 2015 | Volume 6 | Article 122 | 2
Lin et al. Klebsiella pneumoniae pneumonia
Table 1 | Clinical features of CAP versus HCAP caused by Klebsiella pneumoniae.
Characteristic CAP (n = 47) HCAP (n = 44) P -value
Age (year), mean ± SD 76.9 ± 12.2 80.0 ± 11.1 0.387
Male sex 36 (76.6) 40 (90.9) 0.066
Underlying diseases
Diabetes mellitus 21 (44.7) 21 (47.7) 0.771
Malignancy 13 (27.7) 16 (36.4) 0.373
Neurological disorders 10 (21.3) 15 (34.1) 0.171
Chronic kidney disease stage ≥4 4 (8.5) 9 (20.5) 0.104
Chronic lung diseases 15 (31.9) 10 (22.7) 0.326
Liver cirrhosis 2 (6.7) 1 (3.6) 1.000
Alcoholism 4 (8.5) 3 (6.8) 1.000
Congestive heart failure 8 (17.0) 6 (13.6) 0.655
Charlson Comorbidity Index 2.5 ± 1.9 4.0 ± 2.7 0.003
PSI score 135.3 ± 32.9 153.3 ± 43.7 0.030
PSI, class IV and V 41 (87.2) 41 (93.2) 0.487
PSI, class V 29 (61.7) 31 (70.5) 0.379
Days of hospitalization 23.3 ± 20.2 21.8 ± 17.7 0.695
Initial presentation with septic shock 22 (46.8) 13 (29.5) 0.091
Initial presentation with respiratory failure 23 (48.9) 23 (52.3) 0.750
Requirement of mechanical ventilation during the course 18 (38.3) 21 (47.7) 0.364
Intensive care unit admission 30 (63.8) 26 (59.1) 0.642
Complicated with bacteraemia 12 (25.5) 12 (27.3) 0.851
Appropriate antibiotics 45 (95.7) 35 (79.5) 0.018
Early mortality (deaths ≤48 h) 4 (8.5) 5 (11.4) 0.734
28-day mortality 12 (25.5) 15 (34.1) 0.372
In-hospital mortality 14 (29.8) 17 (38.6) 0.373
Values given as mean ± SD or number of patients (%).
in the isolates with capsular types K1, K2, K5, K20, K54, and K57
(Table 3).
CAPSULAR TYPE OF K. pneumoniae ISOLATED FROM NASOPHARYNX
IN OUTPATIENTS
Seventy-one isolates from the nasopharyngeal region collected
consecutively in otorhinolaryngologyoutpatient clinicswere avail-
able for capsular genotyping. Of the 71 patients (45weremale), the
mean agewas 55.3± 15.6 years. Most patients (57/71, 80.2%)were
healthy and no underlying diseases were documented. Diabetes
mellitus (6/14, 42.9%) and malignancy (6/14, 42.9%) were the
most common underlying diseases among the other 14 patients.
Most of them did not receive any antibiotic in the visit. K. pneu-
moniae accounted for 11.5% (39/340) of all bacteria isolated
from nasopharyngeal region from November, 2013 to February,
2014.
Thedetailed capsular types are shown inTable 2. Capsular types
K1, K2, K5, K20, K54, and K57 accounted for ∼70% (n = 49) of
all the K. pneumoniae isolates. Plasmid rmpA and rmpA2 genes
were identiﬁed in 55 and 52 isolates, respectively. All K. pneu-
moniae isolates that belonged to these six capsular types carried
plasmid rmpA or rmpA2 genes. Sixty-eight K. pneumoniae isolates
showed the wild-type antibiotic susceptibility. Among the other
three isolates, one showed an extended-spectrumβ-lactamase phe-
notype, and the other two showed resistance to ﬂuoroquinolones.
The detailed MLST proﬁles in the capsular types K1, K2, K5, K20,
K54, and K57 isolates are shown in Table 3. ST23, ST65, ST86,
ST373, ST375, ST705, ST268, ST29, ST218, and ST592 were found
in isolates from both pneumonia and the nasopharynx.
COMPARISON OF MICROBIOLOGICAL CHARACTERISTICS AMONG K.
pneumoniae ISOLATES COLLECTED FROM PATIENTS WITH
COMMUNITY-ONSET PNEUMONIA AND OUTPATIENTS
Regarding the microbiological characteristics (Table 4), the
proportion of capsular type K1, K2, K5, K20, K54, and
K57, wild-type antibiotic susceptibility and presence of plas-
mid rmpA/A2 were signiﬁcantly higher in isolates from CAP
than those from HCAP. In other words, 8.5% of CAP, 36.4%
of HCAP, and 4.2% of outpatients isolates showed multidrug
resistance. The characteristics were similar between isolates from
CAP and outpatients. However, the proportion of wild-type
antibiotic susceptibility and presence of plasmid rmpA/A2 were
signiﬁcantly higher in isolates from outpatients than those from
HCAP.
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Table 2 | Capsular type distribution among K. pneumoniae isolates
collected from patients with community-onset pneumonia and
nasopharynx from outpatients.
Capsular
type
CAP isolates
No. (n = 47)
HCAP isolates
No. (n = 44)
Nasopharynx from
outpatients No.
(n = 71)
K1 13 9 14
K2 12 9 20
K3 0 1 1
K5 2 1 2
K10 0 1 0
K16 3 0 2
K20 3 2 5
K21 1 0 0
K22 0 1 0
K25 0 0 1
K28 0 1 0
K37 0 1 0
K39 0 0 1
K52 0 0 3
K54 3 2 3
K57 3 2 5
K58 0 1 0
K61 0 1 0
K62 2 2 6
K64 0 3 4
K68 1 0 0
K74 0 1 0
K79 1 1 0
Othersa 3 5 4
aOther capsular types included KN2 (n = 3), probable new capsular types (n = 4)
and non-typeable (n = 1).
RISK FACTORS FOR MORTALITY
Univariate analyses of the factors associated with 28-day mor-
tality are shown in Table 5. The microbiological characteristics
of K. pneumoniae were not associated with mortality. The logis-
tic regression model showed that malignancy [odds ratio (OR)
4.08, 95% conﬁdence interval (CI) 1.32–12.66, P = 0.015) and
PSI scores (OR 1.017, 95% CI 1.001–1.034, P = 0.042) were
independent risk factors for 28-day mortality. Initial presentation
with respiratory failure (OR 3.38, 95% CI 0.99–11.44, P = 0.051)
showed borderline signiﬁcance in predicting mortality.
DISCUSSION
The present study demonstrated the clinical features of
community-onset K. pneumoniae pneumonia as well as the dis-
tribution of capsular types and MLST of K. pneumoniae in a
medical center in Taiwan. We found a high mortality (29.7%)
among these patients. Capsular types K1, K2, K5, K20, K54, and
K57 accounted for ∼70% of all the K. pneumoniae isolates from
Table 3 | MLST profiles among K. pneumoniae isolates collected from
patients with community-onset pneumonia and nasopharynx from
outpatients.
Capsular type and
MLST profiles
CAP No.
(n = 36)
HCAP No.
(n = 25)
Nasopharynx from
outpatients No.
(n = 49)
K1 13 9 14
ST23 13 9 13
ST260 0 0 1
K2 12 9 20
ST65 4 3 8
ST86 5 2 9
ST373 1 2 2
ST375 2 2 1
K5 2 1 2
ST76 1 0 0
ST660 1 0 0
ST705 0 1 0
ST1049 0 0 2
K20 3 2 5
ST268 2 1 2
ST420 1 1 0
ST1544 0 0 3
K54 3 2 3
ST29 3 1 2
ST714 0 0 1
ST889 0 1 0
K57 3 2 5
ST218 1 0 2
ST592 2 2 3
Values given as number of patients.
patients with pneumonia, and ∼70% of K. pneumoniae isolates
from the nasopharynx in adults attending otorhinolaryngology
outpatient clinics. The MLST proﬁles further demonstrated sev-
eral clones common in both pneumonia isolates and those from
the nasopharynx.
Only one study has investigated a series of K. pneumoniae
LRTIs and documented the high fatality rate (15/40, 37.5%) in
Cambodia (Rammaert et al., 2012). The current study demon-
strated community-onset pneumonia with K. pneumoniae had
high mortality (29.7%) despite being in a developed country with
well-equipped healthcare facilities. Generally, the 30-day mortal-
ity rate of CAP is 7.3% in Asia (Song et al., 2008). The mortality
rate of overall CAP is 8.3% in Taiwan (Lauderdale et al., 2005). The
high mortality caused by K. pneumoniae suggested that the viru-
lent strains played an important role in pneumonia. Our previous
studies showed high mortality in bacteremic CAP caused by K.
pneumoniae (Lin et al., 2010b). The current study demonstrated
that community-onset K. pneumoniae pneumonia is a critical
problem in the modern era in endemic areas.
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Table 4 | Comparison of microbiological characteristics among K. pneumoniae isolates collected from patients with community-onset
pneumonia and nasopharynx from outpatients.
Characteristic CAP No.
(n = 47)
HCAP No.
(n = 44)
Nasopharynx from
outpatients No. (n = 71)
P -value:CAP
vs. HCAP
P -value: CAP
vs outpatient
P -value: HCAP
vs outpatient
Capsular type K1 13 (27.7) 9 (20.5) 14 (19.7) 0.422 0.315 0.924
Capsular type K2 12 (25.5) 9 (20.5) 20 (28.2) 0.566 0.752 0.355
Capsular type K1 and K2 25 (53.2) 18 (40.9) 34 (47.9) 0.241 0.573 0.465
Capsular type K1, K2, K5, K20, K54, and K57 36 (76.6) 25 (56.8) 49 (69.0) 0.045 0.369 0.184
Presence of plasmid rmpA 40 (85.1) 25 (56.8) 55 (77.5) 0.003 0.305 0.019
Presence of plasmid rmpA2 39 (83.0) 24 (54.5) 52 (73.2) 0.003 0.233 0.069
Wild-type antibiotic susceptibility 43 (91.5) 28 (63.6) 68 (95.8) 0.001 0.335 <0.001
Values given as number of patients (%).
Table 5 | Factors associated with 28-day mortality in adult patients with community-acquired pneumonia (CAP) caused by K. pneumoniae.
Univariate analysis
Characteristic Survival (n = 64) Death (n = 27) P -value
Age, mean years ± SD 77.8 ± 12.5 80.0 ± 9.8 0.964
Male sex 53 (82.8) 23 (85.2) 0.781
Underlying diseases
Diabetes mellitus 30 (46.9) 12 (44.4) 0.832
Malignancy 15 (23.4) 14 (51.9) 0.010
Neurological disorders 18 (28.1) 7 (25.9) 0.830
Chronic kidney disease stage ≥ 4 9 (14.1) 4 (14.8) 0.925
Chronic lung diseases 19 (29.7) 6 (22.2) 0.468
Liver cirrhosis 1 (1.6) 2 (7.4) 0.195
Alcoholism 5 (7.8) 2 (7.4) 0.947
Congestive heart failure 11 (17.2) 3 (11.1) 0.466
Charlson comorbidity index 2.8 ± 2.0 4.3 ± 3.0 0.015
Healthcare associated pneumonia 29 (45.3) 15 (55.6) 0.373
Pneumonia Severity Index (PSI), score 134.1 ± 35.0 167.4 ± 39.8 0.001
Initial presentation with septic shock 20 (31.3) 15 (55.6) 0.032
Initial presentation with respiratory failure 26 (40.6) 20 (74.1) 0.005
Intensive care unit admission 35 (54.7) 21 (77.8) 0.043
Complicated with bacteremia 9 (14.1) 3 (11.1) 0.704
Appropriate antibiotics 57 (89.7) 23 (85.2) 0.606
Capsular type K1 and K2 31 (48.4) 12 (44.4) 0.727
Capsular type K1, K2, K5, K20, K54, and K57 43 (67.2) 18 (66.7) 0.977
Presence of plasmid rmpA 47 (73.4) 18 (66.7) 0.514
Presence of plasmid rmpA2 46 (71.9) 17 (63.0) 0.402
Wild-type antibiotic susceptibility 51 (79.7) 20 (74.1) 0.556
Values given as mean ± SD or number of patients (%). ICU, intensive care unit.
The capsule is a major virulence factor of K. pneumoniae,
and some capsular types are related to the invasive syndromes
(Chung et al., 2012; Siu et al., 2012). The distribution of capsu-
lar types in each K. pneumoniae-related disease could be crucial
for disease control and prevention. We determined the capsu-
lar types of K. pneumoniae from community-onset pneumonia.
We found that capsular types K1, K2, K5, K20, K54, and K57
were prevalent in community-onset pneumonia, which have been
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reported as the major types for liver abscess in Taiwan (Fang
et al., 2007). Most of the applications of MLST for K. pneu-
moniae were for drug-resistant strains and only a few studies
have applied MLST to virulent strains (capsular type K1 or K2;
Siu et al., 2011; Liao et al., 2014). In the current study, we ana-
lyzed the MLST among the virulent capsular types (K1, K2, K5,
K20, K54, and K57) from pneumonia, and we found several
ST types were prevalent in pneumonia isolates. These virulent
clones and the associated increased epidemic potential may be
associated with the spread in the community in endemic areas.
In western countries, investigations about capsular types of K.
pneumoniae have rarely been reported. One large-scale study con-
ducted in Europe and North America several decades ago has
found that K2 represented the most common types (8.9%) among
bacteremic isolates (Cryz et al., 1986). This suggest that capsular
K2 type K. pneumoniae may be the global threat in this invasive
disease.
Patients with HCAP had more exposure to healthcare envi-
ronments or procedures, and the isolates may have the mul-
tidrug resistant problems. However, the virulence factors between
CAP and HCAP caused by K. pneumoniae have never been
compared. In this study, HCAP patients had a signiﬁcantly
higher Charlson Comorbidity Index and PSI score than CAP
patients had. However, the number of capsular type K1, K2,
K5, K20, K54, and K57, and wild-type antibiotic susceptibil-
ity strains were more common in CAP than HCAP. Overall,
most of the isolates in this study showed wild-type antibiotic
susceptibility. Our previous study on community-onset K. pneu-
monia bacteremia also displayed the prevalent wild-type antibiotic
susceptibility isolates (Wu et al., 2012). Although the virulent
but less drug-resistant isolates were rarely identiﬁed in west-
ern countries, they were indeed widespread in Taiwan and Asia
countries. It is the remarkable features of K. pneumoniae iso-
lates in Taiwan. These virulent capsular types are considered
to be closely associated with community-acquired invasive dis-
ease or pathogenicity, and are rarely identiﬁed in nosocomial
strains (Turton et al., 2010; Lin et al., 2014). We found that
capsular type K1/K2, traditionally known as the most virulent
strains of K. pneumoniae types, accounted for 40% of cases
of HCAP. We cannot ignore the possible risk of progression
to nosocomial spread of these invasive strains, which might
result in severe therapeutic problems in immunocompromised
hosts.
In our previous study, we suggested that the route of entry in
liver abscess is from the gastrointestinal tract (Fung et al., 2012;
Lin et al., 2013). We also indicated that none of 49 patients with
bacteremic CAP caused by K. pneumoniae showed development
of K. pneumoniae liver abscess concomitantly (Lin et al., 2010b).
The pathogenesis of pneumonia and liver abscess may be different
and the gastrointestinal tract carriage may not be related to pneu-
monia. Pharyngeal carriage of K. pneumoniae was considered to
potentially play a role in the pathogenesis of K. pneumoniae pneu-
monia in recent studies from Asia (Farida et al., 2013; Dao et al.,
2014). Farida et al. have shown that the carriage rate of K. pneu-
moniae in healthy individuals in Semarang, Indonesia, exceeds
that of S. pneumoniae in adults (Farida et al., 2013). Almost all
K. pneumoniae strains have the wild-type antibiotic susceptibility
to common antimicrobial agents; similar to those found in CAP
patients in Semarang, Indonesia (Farida et al., 2013). In our ﬁnd-
ings, most patients from outpatient departments were healthy and
had no underlying diseases. Therefore, the ﬁndings may represent
the colonization status and distribution of capsular types in the
general population. Consistent with the recent study conducted
by Farida et al. (2013), nearly all the strains from the nasophar-
ynx in our study showed wild-type antibiotic susceptibility. The
high prevalence of virulent capsular types (K1, K2, K5, K20, K54,
and K57) in the community setting may correspond to the isolates
from community-onset pneumonia. The MLST proﬁles further
demonstrated the genetic relatedness between pneumonia iso-
lates and those from the nasopharynx. Several ST types, such as
ST23, ST65, and ST86, were prevalent in both pneumonia and
the nasopharynx. These ﬁndings are a ﬁrst step in elucidating
potential pathways leading to community-onset pneumonia with
K. pneumoniae.
Our study was limited by its retrospective design. How-
ever, our data have important clinical implications because of
the lack of capsular types from pneumonia and the nasopha-
ryngeal region reported in the literature. The other limita-
tion was that we could not explore the association between
infection and colonization precisely because of the different
groups studied. A future prospective study would give us
the opportunity to detect colonization and infection by the
same K. pneumoniae strain and the associated clinical fea-
tures. Lastly, while most the patients from outpatient depart-
ments had no underlying diseases and did not receive antibi-
otics, they did have upper respiratory tract infections. Col-
lecting nasopharyngeal samples from non-ill healthy adults
could be the best method to investigate the nasopharyn-
geal carriage. Despite this limitation, we give an insight
that community-onset pneumonia could have a reservoir in
the nasopharynx, rather than being spread from speciﬁc
sources.
In conclusion, we found a high mortality (29.7%) among
community-onset K. pneumoniae pneumonia. Capsular types
K1, K2, K5, K20, K54, and K57 accounted for ∼70% of
all the K. pneumoniae isolates from patients with pneumo-
nia, and ∼70% of K. pneumoniae isolates from the nasophar-
ynx in adults attending otorhinolaryngology outpatient clinics.
These six capsular types and wild-type antibiotic susceptibil-
ity strains were more common in CAP than HCAP. The MLST
proﬁles further demonstrated the genetic relatedness between
most pneumonia isolates and those from the nasopharynx. The
similar microbiological characteristics imply that K. pneumo-
niae isolates in the nasopharynx play a role in the patho-
genesis of pneumonia. The distribution of capsular types in
the nasopharynx might have implications for future vaccine
development.
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